2nd Quarter - Report

LINCOLN POLICY GROUP for AMERISOURCEBERGEN CORPORATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals

LobbyistCovered position, as disclosed
DAN ELLING —
COLIN ROSKEY —
THOMAS A SCULLY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 2543 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.